Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p.

Saved in:
Bibliographic Details
Title: Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p.
Authors: Faure-Dupuy S; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany., Riedl T; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Rolland M; Laboratory of Molecular Immunology and Signal Transduction, GIGA-Institute, University of Liège, Liège, Belgium., Hizir Z; Laboratory of Molecular Immunology and Signal Transduction, GIGA-Institute, University of Liège, Liège, Belgium., Reisinger F; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Virology, Helmholtz Zentrum München, Munich, Germany., Neuhaus K; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Schuehle S; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Remouchamps C; Laboratory of Molecular Immunology and Signal Transduction, GIGA-Institute, University of Liège, Liège, Belgium., Gillet N; Integrated Veterinary Research Unit, Namur Research Institute for Life Sciences, Namur, Belgium., Schönung M; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Stadler M; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Wettengel J; Institute of Virology, Helmholtz Zentrum München, Munich, Germany., Barnault R; INSERM, U1052, Cancer Research Center of Lyon (CRCL), University of Lyon (UCBL1), CNRS UMR_5286, Centre Léon Bérard (CLB), Lyon, France., Parent R; INSERM, U1052, Cancer Research Center of Lyon (CRCL), University of Lyon (UCBL1), CNRS UMR_5286, Centre Léon Bérard (CLB), Lyon, France., Schuster LC; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany., Farhat R; INSERM, U1052, Cancer Research Center of Lyon (CRCL), University of Lyon (UCBL1), CNRS UMR_5286, Centre Léon Bérard (CLB), Lyon, France., Prokosch S; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Leuchtenberger C; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Öllinger R; Institute of Molecular Oncology and Functional Genomics, Rechts der Isar University Hospital, Munich, Germany., Engleitner T; Institute of Molecular Oncology and Functional Genomics, Rechts der Isar University Hospital, Munich, Germany., Rippe K; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany., Rad R; Institute of Molecular Oncology and Functional Genomics, Rechts der Isar University Hospital, Munich, Germany., Unger K; Research Unit of Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany., Tscharahganeh D; Helmholtz-University Group 'Cell Plasticity and Epigenetic Remodeling', German Cancer Research Center (DKFZ) and Institute of Pathology University Hospital, Heidelberg, Germany., Lipka DB; Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Faculty of Medicine, Otto-von-Guericke-University, Magdeburg, Germany., Protzer U; Institute of Virology, Helmholtz Zentrum München, Munich, Germany., Durantel D; INSERM, U1052, Cancer Research Center of Lyon (CRCL), University of Lyon (UCBL1), CNRS UMR_5286, Centre Léon Bérard (CLB), Lyon, France., Lucifora J; INSERM, U1052, Cancer Research Center of Lyon (CRCL), University of Lyon (UCBL1), CNRS UMR_5286, Centre Léon Bérard (CLB), Lyon, France., Dejardin E; Laboratory of Molecular Immunology and Signal Transduction, GIGA-Institute, University of Liège, Liège, Belgium., Heikenwälder M; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
Source: JHEP reports : innovation in hepatology [JHEP Rep] 2021 Aug 25; Vol. 3 (6), pp. 100354. Date of Electronic Publication: 2021 Aug 25 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101761237 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5559 (Electronic) Linking ISSN: 25895559 NLM ISO Abbreviation: JHEP Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-5559
DOI:10.1016/j.jhepr.2021.100354